Naitive
Exceptional Preventative Care Designed For Real Life
HQGB
Team Size16
Open Jobs1
Total Funding-
Latest FundraiseUnknown
TL;DR
What they do: AI platform (OsteoSight) that estimates bone mineral density from routine X‑rays to support orthopedic care
HQ: London (3 Waterhouse Square, Holborn)
Regulatory signal: FDA Breakthrough Device designation for OsteoSight (Oct 2023)
Team size: Approximately 16 employees
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Undiagnosed osteoporosis and suboptimal bone‑health pathways in orthopedic care
Industry
Medtech / Software Development
Funding Track Record
Grant
Most recently disclosed external support reported as a grant led by Innovate UK
Investor Signal
“Innovate UK (grant support); company lists an Investor Director on its About page”